Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma

International Journal of Gynecological Pathology

Volumn 16, Issue 3, 1997, Pages 225-232

  Shroyer, Kenneth R ^a   Stephens, Janet K ^a   Silverberg, Steven G ^b   Markham, Neil ^a   Shroyer, A Laurie ^c   Wilson, Michael L ^d   Enomoto, Takayuki ^e  

^a UNIVERSITY OF COLORADO   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^e OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Carcinoma; Endometrium; Hyperplasia; Telomerase

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; CYSTADENOCARCINOMA; DNA REPLICATION; DNA SYNTHESIS; ENDOMETRIOID CARCINOMA; ENDOMETRITIS; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUTEAL PHASE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; TELOMERE; TUMOR GROWTH;

EID: 0030923751     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199707000-00006     Document Type: Article

References (28)

1. Blackburn EH. Structure and function of telomerase. Nature 1991; 350:569-73.
2. Zakian VA. Telomerase: Beginning to understand the end. Science 1995;270:1601-7.
3. Rhyu MS. Telomeres, telomerase, and immortality. J Natl Cancer hist 1995;87:884-94.
4. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
5. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995;55:2533-6.
6. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995;55:2734-6.
7. Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res 1995:55:3258-62.
8. Hiyama E, Collation L, Kataoka T, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996;88:116-22.
9. Counter CM, Hirte HW, Bacchetti S., Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994;91:2900-4.
10. Li Z-H, Salovaara R, Aaltonen LA, Shibata D. Telomerase activity is commonly detected in hereditary nonpolyposis colorectal cancers. Am J Pathol 1996;148:1075-9.
11. Sommerfeld H-J, Meeker AK, Piatyszek MA. Bova GS, Shay JW, Coffey DS. Telomerase activity: A prevalent marker of malignant human prostate tissue. Cancer Res 1996;56:218-22.
12. Langford LA, Piatyszek MA, Xu R, Schold SC, Shay JW. Telomerase activity in human brain tumors. Lancet 1995;346: 1267-8.
13. Schwartz HS, Juliao SF, Sciadini MF, Miller LK, Butler MG. Telomerase activity and oncogenesis in giant cell tumor of bone. Cancer 1995;75:1094-9.
14. Kurman RJ, Norris HJ. Endometrial hyperplasia and related cellular changes. In: Kurman RJ, ed. Blaustein's pathology of the female genital tract. 4th ed. New York: Springer-Verlag, 1994: 411-37.
15. Norris HJ, Becker RL, Mikel UV. A comparative morphometric and cytomorphometric study of endometrial hyperplasia, atypical hyperplasia and endometrial carcinoma. Hum Pathol 1989;20: 219-23.
16. Gordon AN, Fleischer AC, Dudley BS. Preoperative assessment of myometrial invasion of endometrial adenocarcinoma by sonography (US) and magnetic resonance imagining. Gynecol Oncol 1989; 32:175-9.
17. Silverberg SG. Hyperplasia and carcinoma of the endometrium. Semin Diagn Pathol 1988;5:135-53.
18. Norris HJ, Tavassoli FA, Kurman RJ. Endometrial hyperplasia and carcinoma. Diagnostic considerations. Am J Surg Pathol 1983;7: 839-47.
19. Silverberg SG, Kurman RJ. Tumors of the uterine corpus and gestational trophoblastic disease. Atlas of tumor pathology. 3rd series, Fascicle 3. Washington, D.C.: Armed Forces Institute of Pathology, 1992.
20. Hendrickson MR, Kempson RL. Endometrial epithelial metaplasias; proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification. Am J Surg Pathol 1980;4:525-42.
21. Kraus FT. High-risk and premalignant lesions of the endometrium Am J Surg Pathol 1985;9:31-40.
22. Norris HJ, Connor MP, Kurman RJ. Preinvasive lesions of the endometrium. Clin Obstet Gynaecol 1986;3:725-8.
23. Kurman RJ, Zaino RJ, Norris HJ. Endometrial carcinoma. In: Kurman RJ, ed. Blaustein's pathology the female genital tract. 4th edition. New York: Springer-Verlag, 1994:439-86.
24. Carr BR, Wilson JO. Disorders of the ovary and female reproductive tract. In: KJ Isselbacher, E. Braunwald, JD Wilson, JB Martin, AS Fauci, DL Kasper, eds. Harrison's Principles of Internal Medicine. 13th ed. McGraw-Hill, Inc. New York, 1994:2021-2.
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem 1976;72:248-54.
26. Rosner BA. Fundamentals of biostatistics. Boston: Duxbury Press, 1982:225-253, 308-17.
27. Mehta CR, Patel NR. A network algorithm for performing Fisher's exact test in rxc contingency tables. J Am Stat Assoc 1983;78:427-34.
28. Strahl C, Blackburn EH. Effects of reverse transcriptase inhibitors on telomeric length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 1996;16:53-65.